Targeting PCSK9 to reduce residual risk in ACS
Crossref DOI link: https://doi.org/10.1038/s41569-018-0125-6
Published Online: 2018-11-26
Published Print: 2019-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fernández-Ruiz, Irene
Text and Data Mining valid from 2018-11-26
Article History
First Online: 26 November 2018